Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 27, 2020
Mapp has contracted Avid to provide process transfer, scale-up and clinical manufacturing services to support one of its development programs for a novel antiviral drug candidate.
read more
Avid announced that Acumen has selected Avid to provide process development and clinical manufacturing services in support of ACU193.
read more
Iovance Biotherapeutics has selected Avid to provide process development, pilot-batch manufacturing and CGMP manufacturing services to support development of IOV-3001.
read more
Wednesday, November 02, 2022
Avirmax CMC Inc. has completed its brand-new facility in Hayward, CA (San Francisco Bay Area). The facility has received cGMP license approval by the California Department of Public Health (CDPH)-Food & Drug Branch, for the production of rAAV drug ...
read more
Tuesday, December 19, 2017
Avista has completed extensive facility upgrades at its Longmont, Colorado site.
read more
Avista Healthcare and Envigo, an early stage non-clinical contract research organization jointly announced that they have entered into a definitive merger agreement.
read more
Avista Pharma Solutions has completed the acquisition of Solid Form Solutions located in Edinburgh, Scotland.
read more
Thursday, September 08, 2016
Avista Pharma Solutions has announced the sale of its facility in Eagan, Minn. to Microbiology Research Associates, a portfolio company of Thompson Street Capital Partners.
read more
Avista Pharma Solutions, Inc. has initiated a significant expansion and enhancement of its contract testing facility in Agawam, Mass.
read more
Wednesday, August 30, 2017
Avista Pharma Solutions announced Eric Evans has been named its Chief Financial Officer effective August 28, 2017.
read more
Monday, November 13, 2017
Avista Pharma Solutions has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, Colorado site.
read more
Avista Pharma Solutions, Inc has announced that the $4 million expansion of its 26,000-square foot contract testing facility in Agawam, Massachusetts is now complete. For over 30 years, the Agawam site has provided superior service to pharmaceutical ...
read more
Tuesday, February 09, 2016
Avista Pharma Solutions has appointed Eric Setzer as Chief Financial Officer (CFO). Mr. Setzer is a finance and operations executive with over twenty years of experience in various roles within growing technology and life science companies.
read more
Thursday, August 14, 2025
Avista Therapeutics and Forge Biologics announced a strategic partnership to advance the development and manufacturing of AVST-101, Avista’s lead gene therapy candidate targeting X-linked retinoschisis (XLRS), a serious inherited retinal disease.
read more
Avixgen, a subsidiary of Dx&Vx, has signed a licensing-out agreement worth approximately $360M with a U.S. biotechnology company for its next-generation drug delivery platform, ACP (Advanced Cell Penetrating Peptide). Avixgen is a drug development ...
read more